Dong-a St Co., Ltd.

This is the first study in people to test a new drug called DA 3501 for advanced stomach and pancreatic cancers. The main goals are to find a safe and effective dose and to see how the body handles the drug. About 51 patients with specific types of these cancers will receive the …

This study is testing if adding a new investigational drug called DA-2811 to a person's current two-drug diabetes regimen can help lower blood sugar levels more effectively. It will involve about 288 adults with type 2 diabetes whose blood sugar is still too high despite their cu…

This study is testing whether adding a new medication called DA-5218 helps people with type 2 diabetes who still have high blood sugar despite taking metformin. It will involve about 238 adults and compare the new drug against another standard treatment to see which is better at …

This early-stage study aims to understand how a new drug called DA-1229_01 is absorbed and processed by the body after participants eat a meal. It will involve 36 healthy volunteers to measure drug levels in the blood and check for any side effects. The main goal is to gather bas…